Article
Established and novel human translational models to advance cystic fibrosis research, drug discovery, and optimize CFTR-targeting therapeutics.
Current opinion in pharmacology - 1 Jun 2022
Cholon Deborah M, Gentzsch Martina
Abstract excerpt
To find a cure for cystic fibrosis, there has been tremendous progress in the development of treatments that target the basic defect in the protein channel, CFTR. However, 10% of cystic fibrosis patients have rare CFTR mutations that are still without an approved CFTR-targeting drug. To identify relevant therapies for these patients, culture models using nasal, bronchial, and rectal tissue from individual...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
